A Missouri jury has returned a verdict of $55 million on behalf of a woman who contracted ovarian cancer as a result of her use of Johnson & Johnson’s baby powder. This verdict comes two months after a $72 million verdict on behalf of another cancer victim.
The Plaintiff, Gloria Ristesund, testified that she used Johnson & Johnson’s talc-based products on her perineal area for decades. After being diagnosed with ovarian cancer, Ristesund was forced to undergo a hysterectomy and related procedures. Fortunately, her cancer is now in remission.
Johnson & Johnson continues to dispute the allegations that its Baby Power and Shower-to-Shower products (which are composed primarily of talcum powder) can lead to the development of ovarian cancer. However, as we’ve discussed before, scientists at some of the leading medical schools in the United States have long considered talc to be a carcinogen.
In fact, as early as 1971, researchers in Great Britain were identifying talc particles buried deep within the cancerous tissue of ovaries removed from women suffering from ovarian cancer. The picture shown below is a microscopic image of cancerous ovarian tissue, magnified 30,000 times. The image was featured in the March 1971 edition of The Journal of Obstetrics and Gynecology of the British Commonwealth and depicts the tell-tale “decoration pattern” of a talc grain implanted within the tumor.
We are using similar methods to identify which of our clients have suffered from talc-related ovarian cancer. Forensic laboratories preserve tissue samples from hysterectomies and oophorectomies for a minimum of ten years, giving cancer survivors a means of analyzing whether their illness was caused by exposure to talc.
With the next ovarian cancer trial scheduled for July of 2016, this class of litigation is only just getting started. Our law firm is investigating many cases of ovarian cancer across the State of South Carolina. If you would like to speak to a Columbia SC personal injury lawyer at Chappell Smith & Arden, P.A. about your potential case, please call us at 1 866-881-8623 or contact us online.